GlassScriptPhysician profile
Kelly Joyner
NPI 1184397291
$3,125.26
in general payments reported to CMS, 2019-2025
25 companies · $980 in 2025
The $980 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $350 · 2023: $530 · 2024: $1,266 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,775.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $591.31 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $443.45 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $318.81 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $303.03 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $213.86 | 2022-2023 | Lifevest |
| Kestra Medical Technology Services, INC. | $189.48 | 2022-2024 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.06 | 2022-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $144.17 | 2022-2025 | Verquvo, Capvaxive |
| Heartflow, INC. | $107.52 | 2024-2025 | |
| Philips North America LLC | $104.80 | 2023-2025 | (Ck7) Extended Holter, Holter, (Ck4) Mcot |
| Astrazeneca Pharmaceuticals LP | $83.55 | 2022-2025 | Farxiga |
| Alnylam Pharmaceuticals INC. | $60.18 | 2024-2025 | Amvuttra |
| Scpharmaceuticals INC. | $55.45 | 2024-2025 | |
| Edwards Lifesciences Corporation | $52.36 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $48.65 | 2025 | Wegovy |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $38.29 | 2022-2023 | Connected Or Cart |
| Bayer Healthcare Pharmaceuticals INC. | $32.79 | 2025 | |
| Ge Healthcare | $26.18 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $24.92 | 2024 | Arcalyst |
| Endotronix, INC. | $24.39 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Bridgebio Pharma, INC. | $24.19 | 2025 | Attruby |
| Esperion Therapeutics, INC. | $19.76 | 2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $19.65 | 2024 | Xarelto |
| Cleerly, INC. | $19.21 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Lexicon Pharmaceuticals, INC. | $16.20 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Joyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.